SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Millennium Pharmaceuticals, Inc. (MLNM)
An SI Board Since February 1997
Posts SubjectMarks Bans Symbol
3044 135 0 MLNM
Emcee:  icanpickem Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2969Nereus Pharmaceuticals to Present Research at the Annual Meeting of the AmericanIcebrg-11/27/2007
2968Cancer drug works by overactivating cancer gene Melanoma tumors carry enemy witIcebrg-11/21/2007
2967Antimalarial activity of the anticancer and proteasome inhibitor bortezomib and Icebrg-11/17/2007
2966Inhibition of Interleukin-6 Signaling with CNTO 328 Enhances the Activity of BorIcebrg-11/17/2007
2965Synergistic interaction of the histone deacetylase inhibitor SAHA with the proteIcebrg-11/17/2007
2964Combination of proteasome inhibitors bortezomib and NPI-0052 trigger in vivo synIcebrg-11/17/2007
2963ACG: Natalizumab Demonstrates Activity in Crohn's Disease After Anti-TNF FaiIcebrg-11/16/2007
2962CHMP Adopts Negative Opinion on Appeal on European Application For natalizumab fIcebrg-11/16/2007
2961Dunsire talks to Reuters (video). reuters.comIcebrg-11/15/2007
2960Millennium keeps cool head amid acquisition heat Thu Nov 15, 2007 1:32pm EST ByIcebrg-11/15/2007
2959Millennium Pharmaceuticals "outperform" Monday, November 12, 2007 5:1Icebrg-11/12/2007
2958ASH-abstract are now available on-line. The searchword bortezomib produces 224 hIcebrg-11/9/2007
29572:18PM Millennium Pharm announces MLN1202 significantly reduced marker of systemIan@SI-11/6/2007
2956New 52 week high again for MLNM on upgrade from Cowen. 3rd upgrade since mid ocSteve Lokness-11/6/2007
2955Less of Schering-Plough clot drug works, safer Sun Nov 4, 2007 2:53pm EST URL: Icebrg-11/5/2007
2954Nancy Simonian, M.D., Chief Medical Officer, Clinical, Medical and Regulatory AfIcebrg-11/2/2007
2953Anna Protopapas, Senior Vice President, Corporate Development, was lucky enough Icebrg-11/2/2007
2952Millennium Reports Outstanding Third-Quarter Results Driven by VELCADE(R) (BorteIcebrg-11/1/2007
2951Antimalarial activity of the anticancer and proteasome inhibitor bortezomib and Icebrg-10/25/2007
2950A Phase II Study of Single Agent Bortezomib in Patients with Metastatic Breast CIcebrg-10/24/2007
2949Bortezomib down-regulates the cell surface expression of HLA-class I and enhanceIcebrg-10/23/2007
2948[Proteasome inhibitors in the treatment of childhood cancer -- caution?] >&gtuck-10/19/2007
2947Insider buying (almost) There were two Form 4s today: Anthony Wild takes 1.143Icebrg-10/17/2007
2946FDA Expands VELCADE(R) (Bortezomib) for Injection Label for Patients with MultipIcebrg-10/15/2007
2945Barron's summary of the same report... <b>A New Era for Millennium PhIan@SI-10/12/2007
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News